NME1 and cancer: Indeed, the transactivation of the vascular endothelial growth factor receptor via NM23/NDPK activation of human endothelial purinergic receptors offers a framework for the dramatic ability of the nucleotide pathway to promote cancer cell dissemination and angiogenesis.